No non-convertible securities due in Q3 FY2026-27
Prism Medico and Pharmacy has informed stock exchanges that it has not issued any non-convertible securities carrying interest, dividend or principal payments due in the quarter from 1 October to 31 December 2026.
- Quarter
- 1 October to 31 December 2026
- Non-convertible Securities Due
- None issued
- Regulatory Requirement
- SEBI Regulation 57(4) LODR
What happened
Prism Medico and Pharmacy has shared a compliance notice under Regulation 57(4) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
What it means
Public companies must inform stock exchanges before each quarter begins if they have issued any non-convertible securities (such as bonds or debentures) that will require them to pay interest, dividends or return principal during that period. This allows the market to know in advance what cash obligations exist.
In this case, the company states it has not issued any non-convertible securities for which payments are due in Q3 FY2026-27 (1 October–31 December 2026). This means no debt repayments or coupon payments are scheduled for that quarter.
Why it matters
This is a regulatory update, not a business announcement. It does not indicate whether the company is in debt or debt-free overall; it only covers this specific quarter's maturity schedule for non-convertible securities. The absence of such payments in the stated quarter is neutral information for investors—it simply means investors should not expect a near-term cash outflow from the company tied to debt servicing during October–December 2026.
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.